Back to search
FDAFDA · Food and drugs·Recall number D-0007-2018

Mobic (meloxicam) tablets, 15 mg, package in 100-count bottle, Rx only, Dist. by: Boehringer Ingelheim (BI) Pharmaceuticals, Inc., Ridgefield, CT 06877 USA, Lic. from: BI Int'l GmbH, Made in Italy, NDC 0597-0030-01

Published October 18, 2017 · Recall initiated: September 22, 2017

Summary

FDA records drug Class III recall D-0007-2018, published October 18, 2017 and initiated September 22, 2017. Recalling firm: Boehringer Ingelheim Pharmaceuticals, Inc.; Status: Terminated; Reported quantity: 128 bottles; Lot: Lot 754037. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Incorrect or missing package insert. One lot of Mobic Tablets is packaged with an incorrect insert.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Boehringer Ingelheim Pharmaceuticals, Inc.
Distributor
CO, OH
Lot
Lot 754037
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Mobic (meloxicam) tablets, 15 mg, package in 100-count bottle, Rx only, Dist. by: Boehringer Ingelheim (BI) Pharmaceuticals, Inc., Ridgefield, CT 06877 USA, Lic. from: BI Int'l GmbH, Made in Italy, NDC 0597-0030-01 recalled?

Yes. FDA published recall D-0007-2018 on October 18, 2017. Reported hazard: Labeling: Incorrect or missing package insert. One lot of Mobic Tablets is packaged with an incorrect insert.

What should I do if I have this product?

Voluntary: Firm initiated · Letter